Suven Life Sciences Jumps 4.5% After Development in A Clinical Trial for The Treatment of CNS Disorders

The clinical development program being executed through Suven Neurosciences, Inc., a Delaware Company in USA, a whole owned subsidiary of Suven Life Sciences. Suven Life Sciences, a clinical-stage biopharmaceutical company developing novel medicines to treat life-threatening Central Nervous Syste...